Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Endothelin-1 regulation is entangled in a complex web of epigenetic mechanisms in diabetes

S. Biswas, B. Feng, A. Thomas, S. Chen, E. Aref-Eshghi, B. Sadikovic, S. Chakrabarti

. 2018 ; 67 (Suppl. 1) : S115-S125.
. 2018 ; () : S115-S125.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19005334

Endothelial cells (ECs) are primary targets of glucose-induced tissue damage. As a result of hyperglycemia, endothelin-1 (ET-1) is upregulated in organs affected by chronic diabetic complications. The objective of the present study was to identify novel transcriptional mechanisms that influence ET-1 regulation in diabetes. We carried out the investigation in microvascular ECs using multiple approaches. ECs were incubated with 5 mM glucose (NG) or 25 mM glucose (HG) and analyses for DNA methylation, histone methylation, or long non-coding RNA- mediated regulation of ET-1 mRNA were then performed. DNA methylation array analyses demonstrated the presence of hypomethylation in the proximal promoter and 5' UTR/first exon regions of EDN1 following HG culture. Further, globally blocking DNA methylation or histone methylation significantly increased ET-1 mRNA expressions in both NG and HG-treated HRECs. While, knocking down the pathogenetic lncRNAs ANRIL, MALAT1, and ZFAS1 subsequently prevented the glucose-induced upregulation of ET-1 transcripts. Based on our past and present findings, we present a novel paradigm that reveals a complex web of epigenetic mechanisms regulating glucose-induced transcription of ET-1. Improving our understanding of such processes may lead to better targeted therapies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19005334
003      
CZ-PrNML
005      
20210531150507.0
007      
ta
008      
190204s2018 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.933836 $2 doi
035    __
$a (PubMed)29947532
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Biswas, S. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
245    10
$a Endothelin-1 regulation is entangled in a complex web of epigenetic mechanisms in diabetes / $c S. Biswas, B. Feng, A. Thomas, S. Chen, E. Aref-Eshghi, B. Sadikovic, S. Chakrabarti
520    9_
$a Endothelial cells (ECs) are primary targets of glucose-induced tissue damage. As a result of hyperglycemia, endothelin-1 (ET-1) is upregulated in organs affected by chronic diabetic complications. The objective of the present study was to identify novel transcriptional mechanisms that influence ET-1 regulation in diabetes. We carried out the investigation in microvascular ECs using multiple approaches. ECs were incubated with 5 mM glucose (NG) or 25 mM glucose (HG) and analyses for DNA methylation, histone methylation, or long non-coding RNA- mediated regulation of ET-1 mRNA were then performed. DNA methylation array analyses demonstrated the presence of hypomethylation in the proximal promoter and 5' UTR/first exon regions of EDN1 following HG culture. Further, globally blocking DNA methylation or histone methylation significantly increased ET-1 mRNA expressions in both NG and HG-treated HRECs. While, knocking down the pathogenetic lncRNAs ANRIL, MALAT1, and ZFAS1 subsequently prevented the glucose-induced upregulation of ET-1 transcripts. Based on our past and present findings, we present a novel paradigm that reveals a complex web of epigenetic mechanisms regulating glucose-induced transcription of ET-1. Improving our understanding of such processes may lead to better targeted therapies.
650    _2
$a zvířata $7 D000818
650    _2
$a kultivované buňky $7 D002478
650    _2
$a komplikace diabetu $x genetika $x metabolismus $7 D048909
650    _2
$a experimentální diabetes mellitus $x chemicky indukované $x metabolismus $7 D003921
650    _2
$a endoteliální buňky $x účinky léků $x metabolismus $7 D042783
650    _2
$a endotelin-1 $x agonisté $x fyziologie $7 D019332
650    _2
$a epigeneze genetická $x účinky léků $x fyziologie $7 D044127
650    _2
$a glukosa $x toxicita $7 D005947
650    _2
$a lidé $7 D006801
655    _2
$a časopisecké články $7 D016428
700    1_
$a Feng, B. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
700    1_
$a Thomas, A. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
700    1_
$a Chen, S. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
700    1_
$a Aref-Eshghi, E. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
700    1_
$a Sadikovic, B. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
700    1_
$a Chakrabarti, S. $u Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, Suppl. 1 (2018), s. S115-S125
773    0_
$t ET-15 $g (2018), s. S115-S125 $w MED00206979
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29947532 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20190204 $b ABA008
991    __
$a 20210531150506 $b ABA008
999    __
$a ok $b bmc $g 1376297 $s 1043539
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 67 $c Suppl. 1 $d S115-S125 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2018 $d S115-S125 $m ET-15 $x MED00206979
LZP    __
$b NLK118 $a Pubmed-20190204

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...